EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial

Sarbani Ghosh Laskar iD, Shwetabh Sinha, Meenakshi Jeeva iD, Meetakshi Gupta, Shreyasee Karmakar, Anuj Kumar, Samarpita Mohanty, Purabi Mahajan, Shivashankar Timmanpyati, Arun Balaji, Ashwini Budrukkar, Monali Swain und 10 weitere

Head & Neck · 2025-12 · 47 (12) · 3301-3309

DOI: 10.1002/hed.28244 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Head & Neck, online erschienen am 15.07.2025. Verfasst von Sarbani Ghosh Laskar und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Enteral Nutrition, Intubation, Gastrointestinal, Chemoradiotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal feeding strategy (Prophylactic vs. Reactive) during Radiation Therapy (RT) for Head and Neck Cancers (HNC) remains to be established.

Methods

This phase III trial randomized (1:1) patients of HNC to prophylactic [nasogastric tube (NGT) placed at least 1 day before RT starting] versus reactive arm (NGT when required). The primary endpoint was the incidence of significant weight loss at 6 months. Secondary endpoints were weight changes, tube duration, dependence, and compliance.

Results

Due to high denial rates, the trial was prematurely closed. Eighty‐four patients (40‐prophylactic, 44‐reactive) were analyzed intention‐to‐treat. Seventeen patients (39%) required a reactive tube insertion. The proportion of patients with significant weight loss at 6 months in the prophylactic versus reactive arms was 13 (32.5%) versus 10 (15.9%), p = 0.44. The median tube duration was 56 days (IQR: 16.5–91) versus 47 days (IQR: 24–59), p = 0.255.

Conclusion

Our limited analysis found that a reactive NGT should be considered for most HNC patients undergoing RT. Trial Registration Clinical trials registry of India: CTRI/2020/01/023049

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsEnteral NutritionIntubation, GastrointestinalChemoradiotherapyHumansMaleFemaleMiddle AgedAgedWeight LossAdultTreatment Outcome

Stichwörter der Autor:innen

enteral nutritionfeeding tubeprophylactic versus reactive

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Clinical Nutrition, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Speech and Language Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Clinical Research Secretariat, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Head and Neck Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

ORCID-Profile: Sarbani Ghosh Laskar, Meenakshi Jeeva, Shiva Thiagarajan

Zitieren

APA

Laskar, S. G., Sinha, S., Jeeva, M., Gupta, M., Karmakar, S., Kumar, A., Mohanty, S., Mahajan, P., Timmanpyati, S., Balaji, A., Budrukkar, A., Swain, M., Khan, F., Pantvaidya, G., Deshmukh, A., Nair, D., Chaukar, D., Pai, P., Thiagarajan, S., …, & Chaturvedi, P. (2025). Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial. Head & Neck, 47(12), 3301-3309. https://doi.org/10.1002/hed.28244

Vancouver

Laskar SG, Sinha S, Jeeva M, Gupta M, Karmakar S, Kumar A, et al. Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial. Head & Neck. 2025;47(12):3301-3309. doi:10.1002/hed.28244

BibTeX
@article{Laskar2025,
  author = {Laskar, Sarbani Ghosh and Sinha, Shwetabh and Jeeva, Meenakshi and Gupta, Meetakshi and Karmakar, Shreyasee and Kumar, Anuj and Mohanty, Samarpita and Mahajan, Purabi and Timmanpyati, Shivashankar and Balaji, Arun and Budrukkar, Ashwini and Swain, Monali and Khan, Faizalam and Pantvaidya, Gouri and Deshmukh, Anuja and Nair, Deepa and Chaukar, Devendra and Pai, Prathamesh and Thiagarajan, Shiva and Vaish, Richa and Tuljapurkar, Vidisha and Chaturvedi, Pankaj},
  title = {Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial},
  journal = {Head & Neck},
  year = {2025},
  volume = {47},
  number = {12},
  pages = {3301--3309},
  doi = {10.1002/hed.28244}
}
Kostenlos starten →